Inhaled corticosteroids for asthma: impact of practice level device switching on asthma control
Open Access
- 2 January 2009
- journal article
- research article
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 9 (1) , 1
Abstract
As more inhaled corticosteroid (ICS) devices become available, there may be pressure for health-care providers to switch patients with asthma to cheaper inhaler devices. Our objective was to evaluate impact on asthma control of inhaler device switching without an accompanying consultation in general practice. This 2-year retrospective matched cohort study used the UK General Practice Research Database to identify practices where ICS devices were changed without a consultation for ≥5 patients within 3 months. Patients 6–65 years of age from these practices whose ICS device was switched were individually matched with patients using the same ICS device who were not switched. Asthma control over 12 months after the switch was assessed using a composite measure including short-acting β-agonist and oral corticosteroid use, hospitalizations, and subsequent changes to therapy. A total of 824 patients from 55 practices had a device switch and could be matched. Over half (53%) of device switches were from dry powder to metered-dose inhalers. Fewer patients in switched than matched cohort experienced successful treatment based on the composite measure (20% vs. 34%) and more experienced unsuccessful treatment (51% vs. 38%). After adjusting for possible baseline confounding factors, the odds ratio for treatment success in the switched cohort compared with controls was 0.29 (95% confidence interval [CI], 0.19 to 0.44; p < 0.001) and for unsuccessful treatment was 1.92 (95% CI, 1.47 to 2.56; p < 0.001). Switching ICS devices without a consultation was associated with worsened asthma control and is therefore inadvisable.Keywords
This publication has 22 references indexed in Scilit:
- Importance of inhaler devices in the management of airway diseaseRespiratory Medicine, 2008
- The need to improve inhalation technique in Europe: A report from the Aerosol Drug Management Improvement TeamRespiratory Medicine, 2006
- Poor Control Increases the Economic Cost of AsthmaInternational Archives of Allergy and Immunology, 2006
- The public health implications of asthma.2005
- Device Selection and Outcomes of Aerosol Therapy: Evidence-Based GuidelinesChest, 2005
- Clinical and economic effects of suboptimally controlled asthma.2004
- Cost, Morbidity, and Control of Asthma in Hungary: The Hunair StudyJournal of Asthma, 2003
- Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literatureHealth Technology Assessment, 2001
- Risk factors and costs associated with an asthma attackThorax, 2000
- The costs of asthmaEuropean Respiratory Journal, 1996